Learn about Foundayo (orforglipron), the new once-daily weight management tablet authorised in the UK. Understand how it works, eligibility, side effects and UK access.
What Is Orforglipron and How Does the New Weight Loss Pill Work?
Foundayo (orforglipron) is a new once-daily oral medicine for weight management that has recently been authorised for use in the UK. The announcement has attracted considerable interest because Foundayo is a tablet rather than an injection, offering another potential option for eligible adults receiving medical support for weight management.
The Medicines and Healthcare products Regulatory Agency (MHRA) authorised orforglipron, marketed as Foundayo, in the UK on 10 August 2026. The UK is the first European country to authorise the medicine.
If you are searching for information about Foundayo UK, orforglipron, the new Foundayo weight loss pill, or how it compares with other weight-management medicines, this guide explains what is currently known.
Important: Foundayo is a prescription medicine. Whether it is appropriate for you depends on your individual health, medical history and clinical assessment. This article provides general information and is not a substitute for an assessment by a qualified healthcare professional.
What Is Foundayo?
Foundayo is the brand name for orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly.
Unlike injectable GLP-1 medicines, orforglipron is taken as a tablet. It is a non-peptide, small-molecule GLP-1 receptor agonist, which means it works differently from peptide-based medicines that need specific administration conditions.
Foundayo works by activating GLP-1 receptors involved in appetite regulation and metabolic processes. This can help people feel fuller and reduce food intake as part of a clinically supervised weight-management programme.
The UK authorisation of Foundayo represents another development in the growing range of medical treatments available for obesity and weight management.
Is Foundayo Available in the UK?
Yes. This is an important recent change.
The MHRA granted UK authorisation for orforglipron on 10 August 2026 for weight management and type 2 diabetes.
However, MHRA authorisation does not automatically mean that a medicine is available through the NHS.
NHS availability is a separate question involving health technology assessment, commissioning and cost-effectiveness decisions. Therefore, people looking for Foundayo on the NHS should not assume that UK regulatory approval means an NHS prescription is immediately available.
Private prescribing is also subject to an appropriate clinical assessment and the medicine's licensed indications.
How Does Foundayo Work?
Foundayo contains the active ingredient orforglipron, which acts on the body's GLP-1 receptors.
GLP-1 is a naturally occurring hormone involved in appetite and digestion. Medicines that act on GLP-1 receptors can influence appetite and feelings of fullness.
For weight management, the aim is not simply to make someone lose weight quickly. Medical weight-management treatment should form part of a wider approach that considers nutrition, physical activity, behaviour and longer-term health.
Clinical evidence has shown meaningful weight reduction with orforglipron in adults with obesity, although results vary between individuals and clinical-trial results should not be interpreted as a guarantee of a particular amount of weight loss.
How Is Foundayo Taken?
Foundayo is designed to be taken once daily.
One of the features that distinguishes orforglipron from some oral GLP-1 medicines is its dosing flexibility. Current information indicates that Foundayo can be taken with or without food and does not require the same fasting and water restrictions associated with oral semaglutide.
Your prescriber will determine the appropriate starting dose and any subsequent dose changes. Patients should never change their dose themselves, take additional tablets or alter the dosing schedule without medical advice.
Who May Be Suitable for Foundayo?
Weight-management medicines are not suitable for everyone.
Clinical suitability depends on factors such as:
- Your BMI and overall health
- Existing weight-related health conditions
- Current medicines
- Previous weight-management treatments
- Medical history
- Pregnancy or plans for pregnancy
- Other factors identified during your clinical assessment
The UK indication and prescribing requirements should always be checked against the current product information and the assessment carried out by your prescriber.
A consultation is therefore an important part of responsible access to prescription weight-management treatment.
Foundayo and Weight Loss
It is understandable that people searching for Foundayo weight loss results want to know how much weight they could lose.
Clinical trials provide useful information about how a medicine performed in groups of participants, but individual results can be very different.
Factors that may influence weight-management outcomes include:
- Starting weight
- Diet and nutritional intake
- Physical activity
- Treatment adherence
- Dose and treatment duration
- Existing medical conditions
- Other medicines
- Individual response to treatment
For this reason, it is better to view Foundayo as one component of a structured weight-management plan rather than a standalone solution.
At SynovaMed, our approach to weight management includes clinical assessment and ongoing support rather than focusing solely on medication.
Foundayo Side Effects
As with other prescription medicines, Foundayo can cause side effects.
Gastrointestinal effects are among the side effects associated with GLP-1 receptor agonists and may include symptoms such as:
- Nausea
- Diarrhoea
- Vomiting
- Constipation
- Abdominal discomfort
- Reduced appetite
Side effects can vary from person to person and may change during treatment.
If you experience concerning, severe or persistent symptoms, speak to your prescriber or another appropriate healthcare professional.
Do not stop or alter prescribed treatment without seeking appropriate medical advice unless you are experiencing an emergency requiring immediate care.
Foundayo vs Wegovy Pill
One of the most common searches surrounding Foundayo is “Foundayo vs Wegovy pill”.
Both medicines are oral GLP-1 receptor agonists used in weight management, but they contain different active ingredients and have different characteristics.
Foundayo contains orforglipron, while the Wegovy pill contains semaglutide.
Another notable difference is how the medicines are taken. Foundayo is designed to be taken once daily without the same food and water restrictions associated with oral semaglutide.
However, it would be inappropriate to choose one treatment solely on convenience or headline weight-loss figures.
Clinical suitability, medical history, potential side effects, other medicines and individual circumstances should all be considered by a qualified prescriber.
Foundayo vs Mounjaro
People also search for Foundayo vs Mounjaro because both are newer medicines used as part of medical weight management.
However, they are not the same medicine.
Foundayo contains orforglipron and is taken orally.
Mounjaro contains tirzepatide and is administered by injection.
Tirzepatide acts on both GIP and GLP-1 receptors, whereas orforglipron is a GLP-1 receptor agonist.
Because the medicines work differently and clinical trials involve different populations and study designs, comparing percentages from separate trials does not provide a reliable head-to-head comparison.
A clinician can help determine which treatment, if any, is appropriate for your circumstances.
Is Foundayo Better Than Weight Loss Injections?
Not necessarily.
The fact that Foundayo is a tablet may make it appealing to people who prefer oral treatment or who would rather avoid injections. However, convenience does not automatically mean that one medicine is clinically better than another.
Different weight-management medicines have different benefits, risks, dosing schedules and suitability criteria.
Your healthcare professional should consider your circumstances before recommending a treatment.
If you are considering medical weight management, you can explore SynovaMed's weight-management service to understand how the clinical assessment process works.
Foundayo and Lifestyle Changes
Prescription weight-management medicines should not be viewed as a replacement for healthy lifestyle habits.
A sustainable weight-management plan can include:
Balanced nutrition
A nutritious, balanced diet can help provide the protein, fibre, vitamins, minerals and other nutrients your body needs while supporting your treatment goals.
Regular physical activity
Physical activity can support cardiovascular health, muscle strength, fitness and long-term weight management.
Adequate protein
Maintaining adequate protein intake can be particularly important during weight loss because preserving muscle mass is an important consideration.
Hydration
Regular fluid intake is important, particularly if appetite or food intake changes during treatment.
Sleep and routine
Good sleep and consistent daily routines can support healthy eating behaviours and general wellbeing.
Medication can support weight management, but long-term outcomes also depend on the habits and behaviours that surround treatment.
Foundayo in Leicester
Interest in weight management in Leicester and the surrounding Leicestershire area continues to grow as more medical treatment options become available.
For people searching for:
- Foundayo Leicester
- Foundayo UK
- orforglipron Leicester
- weight loss treatment Leicester
- weight management Leicester
- weight loss pharmacy Leicester
- online pharmacy Leicester
- prescription weight management Leicester
- GLP-1 weight management Leicester
- weight loss consultation Leicester
- private weight management Leicester
- weight loss support Leicestershire
it is important to choose a service that follows appropriate UK prescribing and pharmacy requirements.
SynovaMed is a registered pharmacy based in South Wigston, Leicestershire, and provides online healthcare services to patients in the UK. Its website states that prescriptions are reviewed by UK-registered clinicians and that the pharmacy is registered with the General Pharmaceutical Council.
You can learn more about online pharmacy weight management in Leicester and the clinical consultation process before deciding whether medical treatment is appropriate for you.
Choosing an Online Weight Management Service in Leicester
If you are considering an online weight-management service, do not choose a provider based solely on price.
Consider whether the service provides:
- A proper clinical consultation
- Assessment by an appropriately qualified prescriber
- Appropriate checks before prescribing
- Clear information about treatment
- Ongoing clinical support
- A registered pharmacy
- Secure handling of personal information
- Appropriate arrangements for follow-up
- Clear information about potential side effects and when to seek help
SynovaMed describes its service as providing a clinical consultation, clinician review and ongoing support, with medicines dispensed through its UK-registered pharmacy.
For local patients, SynovaMed's pharmacy is located at 11 Blaby Road, South Wigston, Wigston, Leicestershire, LE18 4PA.
Is Foundayo a Prescription Medicine?
Yes.
Foundayo is a prescription medicine and should only be supplied following an appropriate clinical assessment and prescription.
This is particularly important when purchasing medicines online. Avoid websites that offer prescription weight-loss medicines without a proper consultation or appear to bypass normal prescribing requirements.
The MHRA has continued to take action during 2026 against websites and advertising that promote prescription-only weight-loss medicines to the public. UK advertising rules prohibit advertising POMs to the general public, although providers can promote appropriate consultation and treatment services.
Can I Buy Foundayo Online?
As Foundayo is a prescription medicine, legitimate online supply should involve an appropriate clinical assessment and prescription.
Consumers should be particularly cautious of websites offering medicines without asking about their medical history or current medicines.
A legitimate online pharmacy should make it clear who is responsible for the clinical assessment and supply of the medicine.
If you are considering online weight management, you can start a clinical consultation with SynovaMed to find out whether medical treatment may be appropriate for you.
Frequently Asked Questions About Foundayo
What is Foundayo?
Foundayo is the brand name for orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly for conditions including weight management.
Is Foundayo approved in the UK?
Yes. The MHRA authorised orforglipron for weight management and type 2 diabetes on 10 August 2026. The UK became the first European country to authorise the medicine.
Is Foundayo a tablet or injection?
Foundayo is an oral tablet, taken once daily.
What is the active ingredient in Foundayo?
The active ingredient is orforglipron.
Is Foundayo the same as Mounjaro?
No. Foundayo contains orforglipron, while Mounjaro contains tirzepatide. They are different medicines and work through different mechanisms.
Is Foundayo the same as Wegovy?
No. Foundayo contains orforglipron, while Wegovy contains semaglutide. Both act on GLP-1 receptors but are different medicines.
Does Foundayo require fasting?
Unlike oral semaglutide, Foundayo is designed to be taken without the same fasting requirements. Your prescribed instructions should always be followed.
Can everyone take Foundayo?
No. Prescription weight-management medicines are not suitable for everyone. A qualified prescriber needs to assess your medical history, health and individual circumstances.
Can I get Foundayo through the NHS?
UK regulatory authorisation does not automatically mean immediate NHS availability. NHS access is a separate decision involving health technology assessment and commissioning.
Can I get weight-management support in Leicester?
Yes. SynovaMed is a registered pharmacy based in South Wigston, Leicestershire, and provides online clinical services for UK patients.
A Safer Approach to Medical Weight Management
The arrival of Foundayo gives eligible patients another potential option in the expanding field of medical weight management.
However, the right treatment is not necessarily the newest treatment.
A responsible weight-management service should look at the whole person, including health history, lifestyle, current medicines, treatment goals and potential risks.
At SynovaMed, the clinical process includes an online consultation followed by review by a UK-registered prescriber. The service also describes ongoing support and treatment monitoring as part of its approach to weight management.
If you are considering prescription treatment for weight management, learn more about SynovaMed's clinical weight-management service or contact the pharmacy team in Leicestershire to find out more.
Medical Disclaimer
This article is intended for general educational purposes and does not constitute medical advice, diagnosis or treatment. Foundayo (orforglipron) is a prescription medicine and should only be used following an appropriate clinical assessment and prescription. Individual suitability, dosage, potential interactions, side effects and treatment duration should be discussed with a qualified healthcare professional. Always follow the prescribing information supplied with your medicine.

